Urinary Metabonomics of Two Major Patterns of NAFLD
NCT02077283 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2015-11-20
Summary
NAFLD(non-alcoholic fatty liver disease, NAFLD) is a common liver disease with a high morbidity which seriously influence people's health. In clinical, there are two major Traditional chinese medicine(TCM) patterns which are the pattern of "liver depression and spleen deficiency" and pattern of "damp-heat in the interior", According to TCM patterns, the treatment is effective, but not used worldwide. While the development of metabonomics provides a tool to investigate the correlation of TCM patterns and metabonomics which will promote the further development of TCM.
Currently researches on NAFLD patterns based on metabolomics were limited. Our study was undertaken to investigate the correlation of TCM patterns and metabonomics, to evaluate the application of urinary metabonomics in NAFLD: whether it can be used in TCM patterns auxiliary classification of NAFLD. In addition, the investigators also aim to discover novel biomarkers for the noninvasive early diagnosis of nonalcoholic fatty liver disease (NAFLD).
In this study, urine samples from humans of three divided groups (healthy controls, the group of "liver depression and spleen deficiency" pattern and group of "damp-heat in the interior pattern) were collected, then 4℃, 15 min 3000 rpm centrifuged and - 80℃ cryopreserved. The metabolic profile changes were analyzed by Gas Chromatograph-Mass Spectrometer(GC/MS) with principal component analysis (PCA), partial least squares-discriminate analysis (PLS-DA) and orthogonal partial least squares-discriminate analysis (OPLS-DA). Furthermore, biochemical examination were also carried out to compare among these three groups.
Base on literature survey, the investigators inferred that there should be metabolic differences between the two patterns of NAFLD. If the investigators hypothesis is correct, the investigators can find different metabolites which can be used discriminate between NAFLD and healthy population, different patterns through urinary metabonomics.
The results will be attractive which mean a lot: it will prove the importance of the four diagnosis methods of TCM used in differential analysis by metabonomics; it will validate the classification of TCM syndromes is scientific; it will shed light in the study of TCM syndromes; it will find biology markers to help diagnosis, treatment and pattern discrimination.
Conditions
- Non-alcoholic Fatty Liver Disease
Sponsors & Collaborators
-
ShuGuang Hospital
lead OTHER
Principal Investigators
-
mingyu Sun, PhD · Institute of Liver Disease, ShuGuang Hospital, Shanghai University of TCM
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2016-11-30
- Completion
- 2017-11-30
Countries
- China
Study Locations
More Related Trials
-
Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF
NCT06097338 ·Status: NOT_YET_RECRUITING
-
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
NCT04785937 ·Status: RECRUITING ·Phase: NA
-
Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Disease
NCT04946786 ·Status: UNKNOWN
-
Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease
NCT05653830 ·Status: RECRUITING
-
Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
NCT06707129 ·Status: RECRUITING
-
Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN
NCT06157125 ·Status: RECRUITING
-
The Relationship Between Fatty Liver and Breast Cancer
NCT06402084 ·Status: RECRUITING
-
Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese
NCT03282305 ·Status: NOT_YET_RECRUITING
-
NAFLD in Patient of Hypothyroidism
NCT05813301 ·Status: NOT_YET_RECRUITING
-
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
NCT07168551 ·Status: NOT_YET_RECRUITING
-
Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter
NCT06203548 ·Status: RECRUITING ·Phase: NA
-
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
NCT05255978 ·Status: RECRUITING
-
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
NCT05766449 ·Status: RECRUITING
-
Ultrasound and Attenuation Imaging
NCT06552377 ·Status: COMPLETED
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Longitudinal Observational Study Of Chinese With NAFLD/NASH
NCT03151473 ·Status: RECRUITING
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Positive Association of US-FLI With the Severity of CAD
NCT06541132 ·Status: RECRUITING
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Relation Between NAFLD and BM DENSITY
NCT06038253 ·Status: NOT_YET_RECRUITING
-
Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD
NCT04681573 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology
NCT05551884 ·Status: UNKNOWN
-
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension
NCT03277651 ·Status: UNKNOWN
-
Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis
NCT03566173 ·Status: COMPLETED
-
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06487325 ·Status: COMPLETED